5 Most Undervalued Pharma Stocks To Buy According To Analysts

3. Viatris Inc. (NASDAQ:VTRS)

Share Price Upside: 55%

Viatris Inc. (NASDAQ:VTRS) is a global pharmaceutical company that sells drugs for nervous system disorders, cancer, and skin diseases. The firm is currently seeking to reduce its debt burden, and for this purpose, it is selling three business divisions.

Insider Monkey took a look at 910 hedge fund portfolios for 2023’s second quarter and discovered 42 Viatris Inc. (NASDAQ:VTRS) investors. Stephen Dubois’ Camber Capital Management owns the largest stake among these which is worth $224 million.

Follow Viatris Inc